Search

everythinglearnresearchcommunity

for

Search:↓

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

CD2 might be a new treatment target for patchy alopecia areata.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Blood-derived CD34+ cells speed up healing, reduce scarring, and regrow hair in skin wounds.

Ionizable lipid nanoparticles are the best for delivering gene-editing therapies.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

Pantethine may boost the immune system's ability to fight sarcoma.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

CD4+ skin cells may be precursors to basal cell carcinoma.

Ift20 is essential for hair follicle function and skin cell movement.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Vitiligo is influenced by genetics and environment, and combining these factors can improve early detection and prevention.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Composite biomaterials can precisely control immune responses for better disease treatment.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.